InvestorsHub Logo
Followers 3
Posts 801
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Friday, 01/06/2023 9:03:43 PM

Friday, January 06, 2023 9:03:43 PM

Post# of 8545
Ripe for Halozyme and Enhanze: FDA Approves LEQEMBI™ (lecanemab-irmb from Biogen) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
JANUARY 6, 2023

Route of administration for LEQEMBI:

“10 mg/kg administered intravenously once every two weeks”

Source: https://investors.biogen.com/news-releases/news-release-details/fda-approves-leqembitm-lecanemab-irmb-under-accelerated-approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News